Artemis Medicare Services Share Price | Artemis Medicare Services Stock Screener
ARTEMISMED
Hospitals
Share Price NSE
₹279.53
▲
4.31 (1.57%)
Share Price BSE
₹279.45
▲
3.70 (1.34%)
As of May 20, 2026, the Artemis Medicare Services share price (NSE: ARTEMISMED) is ₹279.53 on NSE and ₹279.45 on BSE, up 1.57% from the previous close, with shares trading between ₹262.64 and ₹281.20, and a 52-week range of ₹205.51–₹288.10.
Check ARTEMISMED annual price range for the annual price range and momentum.
Use the Artemis Medicare Services stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Artemis Medicare Services Market Cap
₹4,429.41 Cr.
ARTEMISMED P/E Ratio (TTM)
42.46
Artemis Medicare Services P/B Ratio
5.08
EPS (TTM)
₹6.56
Dividend Yield
0.16%
Debt to Equity
0.53
ARTEMISMED 52 Week High
₹288.10
Artemis Medicare Services 52 Week Low
₹205.51
Operating Margin
18.00%
Profit Margin
10.45%
ARTEMISMED Revenue (TTM)
₹287.00
EBITDA
₹59.00
Net Income
₹30.00
Total Assets
₹1,429.00
Total Equity
₹935.00
Artemis Medicare Services Share Price Chart
Screen Artemis Medicare Services share price with an interactive chart. Analyse ARTEMISMED price trends and volatility across different timeframes.
Artemis Medicare Services Company Profile - Fundamental Screener
Screen Artemis Medicare Services company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ARTEMISMED shares.
Sector
Healthcare Services
Industry
Hospitals
Sub-Sector
Hospitals
Segment
E
ISIN
INE025R01021
Artemis Medicare Services Balance Sheet Screener
Screen ARTEMISMED balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 1,429 | 1,357 | 972 | 905 | 710 | 600 | 586 | 554 |
| Current Assets | 367 | 539 | 180 | 170 | 127 | 110 | 118 | 113 |
| Fixed Assets | 791 | 745 | 719 | 605 | 489 | 383 | 393 | 381 |
| Liabilities | ||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 277 | 298 | 332 | 292 | 210 | 160 | 115 | 84 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 935 | 844 | 455 | 408 | 361 | 322 | 314 | 293 |
| Share Capital | 16 | 14 | 14 | 13 | 13 | 13 | 13 | 13 |
| Reserves & Surplus | 919 | 824 | 435 | 390 | 346 | 307 | 300 | 280 |
Artemis Medicare Services Income Statement Screener - Profit & Revenue Analysis
Screen Artemis Medicare Services income statement and profit fundamentals.
Analyze ARTEMISMED quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Artemis Medicare Services share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 287 | 252 | 262 | 282 | 280 | 227 | 228 | 249 | 241 | 198 | 211 | 227 | 221 | 151 | 170 |
| Expenses | 228 | 204 | 214 | 224 | 231 | 187 | 187 | 199 | 195 | 170 | 182 | 191 | 186 | 132 | 148 |
| EBITDA | 59 | 48 | 48 | 58 | 49 | 40 | 41 | 50 | 46 | 28 | 29 | 37 | 34 | 18 | 22 |
| Operating Profit % | 18.00% | 15.00% | 16.00% | 18.00% | 15.00% | 17.00% | 16.00% | 18.00% | 16.00% | 13.00% | 13.00% | 15.00% | 15.00% | 11.00% | 11.00% |
| Depreciation | 13 | 12 | 11 | 12 | 12 | 11 | 11 | 11 | 11 | 9 | 9 | 10 | 10 | 6 | 7 |
| Interest | 6 | 8 | 7 | 7 | 7 | 9 | 8 | 8 | 8 | 5 | 7 | 8 | 8 | 4 | 4 |
| Profit Before Tax | 40 | 29 | 30 | 39 | 30 | 20 | 22 | 31 | 27 | 14 | 13 | 19 | 16 | 8 | 11 |
| Tax | 10 | 6 | 9 | 9 | 8 | 6 | 5 | 8 | 6 | 3 | 3 | 5 | 5 | -5 | 2 |
| Net Profit | 30 | 23 | 21 | 30 | 22 | 14 | 17 | 22 | 21 | 11 | 10 | 14 | 12 | 13 | 8 |
| EPS | 1.90 | 1.47 | 1.35 | 1.90 | 1.41 | 1.04 | 1.14 | 1.42 | 1.32 | 0.79 | 0.72 | 1.00 | 0.85 | 1.00 | 0.64 |
Artemis Medicare Services Cash Flow Screener - Liquidity Fundamentals
Screen ARTEMISMED cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | 146 | 109 | 127 | 60 | 27 | 56 | 41 |
| Investing Activities | -385 | -88 | -158 | -107 | -37 | -26 | -50 |
| Financing Activities | 267 | -29 | 38 | 44 | 18 | -27 | 14 |
| Net Cash Flow | 27 | -8 | 7 | -4 | 8 | 2 | 5 |
Artemis Medicare Services Shareholding Pattern Screener
See Artemis Medicare Services shareholding pattern with promoter, FII, and DII holdings.
Check Artemis Medicare Services promoter holding and ownership changes for ARTEMISMED on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Nov | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 58.39% | 67.17% | 66.53% | 66.53% | 58.43% | 58.39% | 68.03% | 67.51% |
| FII Holding | 12.19% | 0.31% | 0.24% | 0.37% | 12.48% | 12.47% | 0.10% | 0.16% |
| DII Holding | 2.89% | 5.04% | 4.76% | 4.27% | 3.35% | 2.91% | 2.61% | 3.45% |
| Govt Holding | 6.16% | 7.09% | 7.02% | 7.02% | 6.16% | 6.16% | 7.18% | 7.12% |
| Public Holding | 12.36% | 12.86% | 12.93% | 13.44% | 11.65% | 12.12% | 14.74% | 14.23% |
| Other Holding | 8.01% | 7.53% | 8.52% | 8.37% | 7.93% | 7.96% | 7.34% | 7.53% |
| Shareholder Count | 32,044 | 28,397 | 31,614 | 33,559 | 31,884 | 31,602 | 19,993 | 19,795 |
Artemis Medicare Services Share Dividend Screener - Share Yield Analysis
Check Artemis Medicare Services dividend history with payout and yield data.
View Artemis Medicare Services dividend details including ex-dates and amounts for ARTEMISMED stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.45 | 0.22% |
| 2024-March | ₹0.45 | 0.16% |
| 2023-March | ₹0.45 | 0.26% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Artemis Medicare Services Stock Index Membership
See which indices include Artemis Medicare Services stock.
Check ARTEMISMED index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSE HC
BSE INDEX SMLCAP
Artemis Medicare Services Market Events Screener - Corporate Actions
Get Artemis Medicare Services corporate actions including splits, bonuses, and buybacks.
Check Artemis Medicare Services stock events that may affect ARTEMISMED share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-08 | 2026-05-08 | Quarterly Result Announcement | NA | 6.53% |
| 2026-02-02 | 2026-02-02 | Quarterly Result Announcement | NA | 5.62% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 0.02% |
| 2025-08-05 | 2025-08-05 | Quarterly Result Announcement | NA | 6.20% |
| 2025-07-30 | 2025-07-30 | Annual General Meeting | NA | -3.97% |
| 2025-07-11 | 2025-07-11 | Dividend | ₹ 0.45 /share | 5.08% |
| 2025-05-12 | 2025-05-12 | Quarterly Result Announcement | NA | -8.22% |
| 2025-02-05 | 2025-02-05 | Quarterly Result Announcement | NA | 2.93% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -1.84% |
| 2024-07-24 | 2024-07-24 | Annual General Meeting | NA | 23.92% |
| 2024-07-05 | 2024-07-05 | Dividend | ₹ 0.45 /share | -4.82% |
| 2024-05-03 | 2024-05-03 | Extraordinary General Meeting | NA | -2.08% |
| 2023-07-14 | 2023-07-14 | Dividend | ₹ 0.45 /share | 57.34% |
Artemis Medicare Services Competitors Screener - Peer Comparison
Screen ARTEMISMED competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 116,214 | 62.54 | 21,994 | 14.76% | 1,505 | 64.49 |
| Max Healthcare Institute | 102,189 | 72.00 | 7,184 | 28.68% | 1,076 | 63.41 |
| Fortis Healthcare | 72,752 | 74.73 | 7,850 | 13.25% | 809 | 62.03 |
| Aster DM Healthcare | 39,048 | 90.42 | 4,643 | 8.32% | 384 | 66.43 |
| Narayana Hrudayalaya | 37,625 | 47.59 | 5,575 | 12.29% | 790 | 56.40 |
| Global Health | 33,397 | 63.42 | 3,771 | 12.59% | 481 | 67.36 |
| Krishna Institute of Medical Sciences | 30,477 | 98.51 | 3,067 | 21.98% | 415 | 65.47 |
| Dr. Agarwal's Health Care | 14,260 | 87.99 | 1,757 | 27.64% | 110 | 52.19 |
| Rainbow Childrens Medicare | 13,570 | 51.41 | 1,567 | 17.46% | 244 | 65.23 |
| Park Medi World | 10,559 | 39.26 | 1,679 | 17.77% | 272 | 60.62 |
Artemis Medicare Services Company Announcements - News Screener
Screen ARTEMISMED latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-19 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-14 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-05-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-13 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-05-13 | Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information | - |
| 2026-05-13 | Announcement under Regulation 30 (LODR)-Dividend Updates | - |
| 2026-05-13 | Corporate Action-Board approves Dividend | - |
| 2026-05-13 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-05-12 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-12 | Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Year Ended March 31 2026 | - |
| 2026-05-12 | Board Meeting Outcome for Board Meeting Held On May 8 2026 | - |
| 2026-05-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-05 | Board Meeting Intimation for Consideration Of Audited Financial Results And Recommendation Of Dividend If Any. | - |
| 2026-04-29 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-30 | Closure of Trading Window | - |
| 2026-03-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |